Skip to content
SafetyFor practitioners

Medication in the client questionnaire: ask, do not prescribe or stop it

“An antibiotic” or “an acne cream” is not enough information either to proceed or to refuse treatment. The exact name, dates of use, current protocol and a clear way to obtain medical assessment are needed.

A client writes “taking tablets” on the form. The conversation reveals that it is a course of antibiotics, but they cannot remember the name. A laser hair reduction appointment is waiting, the schedule is full and the skin looks calm. It is very tempting to choose one of two quick answers: yes or no.

There is not yet a responsible answer.

The practitioner’s job at this point is not to identify medicine from its purpose or calculate a safe break from memory. The task is more ordinary and more useful: collect information in a form that supports a proper decision, without crossing the line where a laser practitioner begins to manage somebody else’s medical treatment.

“An antibiotic” and “an ointment” are not names

The same everyday description can conceal different active ingredients, formulations and routes of use. “I take it for inflammation”, “I put it on my face” and “it is only a supplement” describe the person’s attitude to a product, not the product itself. Checking requires the exact name from the packaging or prescription, the formulation, route and dates.

Dates should not remain as a convenient “recently”. Record when the product was started, when the regimen changed and when it ended or is due to end if a doctor has already defined that. For a topical product, note whether it is applied to the proposed treatment area. If the person cannot remember the name, ask for a photograph of the packaging or prescription. Do not guess from a tablet’s colour, its first letter or “something for allergies”.

Dose and regimen are recorded exactly as the client reports them or the document states them. The practitioner does not correct the regimen or judge whether the doctor prescribed appropriately. Even a familiar-looking name can sit on different formulations and similar brands can contain different ingredients. Confidence based on remembering somebody else’s medicine is not verification.

Timing needs to be attached to events rather than a vague memory. “I have been taking it for a second week” should become a start date. “I finished recently” needs the date of the last use. If a doctor changed the regimen, record when that happened. The practitioner does not use these dates to calculate a permitted interval independently. They allow the device instructions and medical reviewer to answer the real question rather than an approximate account.

Sometimes a client provides a long list and the practitioner tries to select only the “suspicious” items.

That defeats the purpose of collecting information. A laser practitioner is not expected to sort medication risk by sight. They are expected to pass the complete relevant list through the clinic’s process, with products applied to the area and anything started or changed since the previous visit clearly marked. Clinical relevance is not decided by how familiar a name looks.

The conversation is not limited to prescription tablets. A person may not regard an over-the-counter painkiller, inhaler, cold remedy, supplement or medicated cream as medicine. They may call an active cosmetic product a “medicine”, even though its composition, the skin condition and the site of application matter more to the process. “Do you take medication?” therefore needs ordinary examples, but not an endless recital of brand names.

A useful question sounds like this: “Please tell me everything you are taking or applying to this area now, and anything that changed since the last visit. If you do not remember the exact name, we will check the packaging instead of guessing.” It does not accuse the client and immediately explains why accuracy matters.

The American Academy of Dermatology advises disclosing medication, including over-the-counter products, before laser treatment, alongside recent tan, a tendency to scar and other relevant circumstances. This is not a ready-made list of permissions. It supports a simple working principle: a decision begins with a complete, current history.

A questionnaire gathers information. It does not authorise the practitioner to change treatment

The most dangerous short sentence in this conversation is: “Stop it for a few days and come in.” However well meant, the practitioner is intervening in prescribed treatment. They do not know why the medicine is needed, what interruption might do or whether the treating doctor permits it.

It is equally inappropriate to advise a lower dose, a missed dose, stopping a topical product or independently replacing it with something “safer”. A paid procedure is not more important than treatment. The client should never have to choose between a doctor’s advice and avoiding the loss of an appointment.

A universal timing table does not solve the problem.

Compatibility depends on more than the name of a drug class. The exact product, route, skin condition, purpose of treatment, instructions for the specific laser device, local protocol and medical assessment can all matter. One interval found online cannot honestly cover those conditions.

A test treatment does not repair missing basic information. It may be part of response assessment where the protocol requires it, but it is not a way around an unknown product or a direct restriction in the instructions. If the team does not know whether the device permits treatment in the circumstances, a smaller area does not make the decision sound. Confirm eligibility first, then follow the required steps.

The working sequence is different. First obtain the exact information. Then check the current instructions for the exact model and mode that would be used, together with the clinic’s approved protocol. If the documents provide a clear restriction, follow it. If they do not answer the question, formulate a specific request to the responsible medical professional or treating doctor.

A specific request is more useful than “please approve laser”. It states the planned procedure, the area, the known information about the product and the exact issue requiring assessment. The practitioner does not ask the doctor to stop medicine or suggest the desired answer. They pass on the information and wait for a decision through the defined route.

Treatment waits while critical information is missing. This may disrupt the schedule, but uncertainty does not become safety because the client has already arrived. At the same time, a postponement should not be presented as proof that the medicine is dangerous. The honest language is: “We do not yet have enough information to make a decision under the protocol. I will clarify the question and tell you the next step.”

Even medical clearance does not become a permanent pass. The practitioner still assesses the skin today, checks new health changes and follows the current device instructions. If the skin is irritated, damaged or otherwise uncertain, the team responds to the present condition instead of sheltering behind an old letter.

The decision must return to the record, and the question must return at the next visit

A strong clinic has a visible route: who checks medication, where the current device instructions are kept, who receives a medical question, in what form the answer returns and who communicates it to the client. If approval exists only as “the doctor apparently said it was fine”, the next practitioner cannot check its context or date.

The record keeps the exact product name, formulation and route, reported dates, source of the information, question referred, answer received and responsible person. If treatment is postponed, record the reason and the condition for reassessment. Do not collect unrelated medical detail out of curiosity.

The note should be sufficient for the decision and protected under the clinic’s confidentiality rules.

The team needs to know what happens in an ordinary shift. Who receives the question in the evening or at the weekend? Who decides when the main reviewer is unavailable? How can the booking move without pressure on the client? If the process works only under a perfect timetable, the team will soon improvise.

The client needs a clear outcome too. Not “reception will message later”, but who will contact them, what is being checked and why treatment has not yet been confirmed. If an answer from the treating doctor is required, provide an understandable request rather than sending the person away “for a letter” with no explanation. The medical pathway should not become a tour between offices carrying a mysterious phrase.

The BMLA treatment guidelines connect medical history, informed consent, testing, documentation and work under a current protocol. The point is not to fill more boxes. It is to make the decision reviewable and reproducible.

Ask again at the next visit. An old medication list is not permanent. Check new products, completed or changed treatment, topical products on the area and any response after the previous procedure. Date a negative answer as well. A short update is more useful than a long form signed once and never reopened.

Tone directly affects the quality of the information. If a client expects a reprimand or financial loss for an honest answer, they may stay silent. When the team calmly explains the possibility of postponement and does not assign blame, reporting a change becomes easier.

The practitioner does not produce an answer by guesswork. They record the exact product and dates, pause the treatment decision and pass the question to the person authorised to provide medical assessment. They neither prescribe nor stop the medicine, but the client leaves with a clear next step.

Sources and scope of use

  1. Laser hair removal: Preparation, American Academy of Dermatology. Use for initial consultation, disclosure of medicines and medical history, avoiding tanning and broad-spectrum SPF 30+ guidance. Do not turn the examples given into a universal list of contraindications.
  2. ASDS Guidelines Task Force: Consensus Recommendations Regarding the Safety of Lasers, Dermabrasion, Chemical Peels, Energy Devices, and Skin Surgery During and After Isotretinoin Use, American Society for Dermatologic Surgery / National Library of Medicine. Use to explain that the evidence does not support an automatic six-month delay for every non-ablative hair-removal laser. Full medicine disclosure, assessment by a qualified professional and the device's current IFU remain mandatory.
  3. Concomitant use of isotretinoin and lasers with implications for future guidelines: An updated systematic review, National Library of Medicine, PubMed. Use for a critical review of outdated universal waiting periods, with clear acknowledgement of evidence limitations. Do not declare isotretinoin use safe under all circumstances.
  4. Safety Information for Lumenis Energy-Based Devices, Lumenis. Use only as an example of warnings, test spots and contraindications for this device family. Before any clinical decision, check the current IFU for the exact model and the requirements of the relevant jurisdiction.
  5. Treatment Guidelines for the Use of Laser and Intense Pulsed Light Devices for Hair Reduction and Treatment of Superficial Vascular and Benign Pigmented Lesions, British Medical Laser Association. Use for consultation, informed consent, test spots, documentation, eye protection, aftercare, equipment checks and incident escalation. Adapt to current local law and the manufacturer's exact instructions.

Open the full source register

Feedback

Ratings and discussion

New ratings and comments are temporarily closed.

Rate this article

Voting results will appear when ratings reopen.

No ratings yet
Voting is temporarily closed

Leave a comment

New comments are temporarily closed. Published discussions will appear in this section.

Comments are temporarily closed.